Compugen (CGEN) Reports In-Line Q4 EPS

Compugen (NASDAQ: CGEN) reported Q4 EPS of ($0.17), in-line with the analyst estimate of ($0.17). Revenue for the quarter came in at $100 thousand versus the consensus estimate of $150 thousand.

For earnings history and earnings-related data on Compugen (CGEN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins